Learn more

NOVOPHARM BIOTECH INC

Overview
  • Total Patents
    28
About

NOVOPHARM BIOTECH INC has a total of 28 patent applications. Its first patent ever was published in 1997. It filed its patents most often in Australia, Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are GENITRIX LLC, NANTCELL INC and MULTIVIR INC.

Patent filings per year

Chart showing NOVOPHARM BIOTECH INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Dan Michael D 11
#2 Kaplan Howard A 10
#3 Maiti Pradip K 7
#4 Kaplan Howard 6
#5 Dan Michael 5
#6 Glassy Mark C 5
#7 Mcknight Michael E 5
#8 Entwistle Joycelyn 4
#9 Tanha Jamshid 3
#10 Kadima Tenshuk A 3

Latest patents

Publication Filing date Title
AU7262700A Enhanced phage display library of human vh fragments and methods for producing same
CA2290722A1 Consensus peptide presenting entities
WO0140292A1 Antigen-binding fragments specific for tumor associated antigens
AU1370300A Antigen-binding fragments specific for tumor associated antigens
CA2288530A1 Immunofluorescence compound for imaging of tumors
CA2282179A1 Enhanced phage display library
AU5241199A Pharmaceutically acceptable composition comprising an aqueous solution of paclitaxel and albumin
AU3242799A Human monoclonal antibodies capable of oligospecifically recognizing the major tumor-associated gangliosides and methods of use thereof
AU8086498A Antisense oligonucleotides and therapeutic use thereof in human immunodeficiencyvirus infection
AU7927398A Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
CA2255540A1 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
AU3369697A Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
WO9739774A1 Human monoclonal antibody specific for melanoma-associated antigen and methods of use
US5811537A Antisense oligonucleotides targeted against human immunodeficiency virus